The first prescription is only one stage of testosterone care. Continuing treatment raises practical questions about appointments, laboratory work, possible adverse effects, and whether the original concerns are improving. A clear plan helps you know who is responsible for answering those questions.
This guide is based on clinical guidance, FDA information, and current provider descriptions checked September 22, 2026. It offers questions to take to your clinician, not a personal testing schedule or instructions to change medication. Monitoring depends on the prescription and individual medical circumstances.
KEEP IN MIND
A few things to remember.
- Monitoring should connect symptoms, laboratory findings, possible harms, and ongoing benefit.
- Ask who orders tests, explains results, and responds between visits.
- Published subscription intervals do not replace an individualized clinical plan.
Ask what improvement will be evaluated
At the beginning, discuss which symptoms or concerns treatment is intended to address and how the clinician will judge benefit. A laboratory number and your experience both need context. If the original problem persists, ask what further explanation or reassessment is appropriate instead of assuming that more testosterone must be the answer.
It can help to keep a brief note of changes you want to discuss at the next visit. Avoid turning every daily fluctuation into a treatment conclusion. The first-conversation guide explains how a clear starting history supports a more useful later discussion.
Sources: Endocrine Society: testosterone therapy clinical guidance
Know how and when to obtain results
Ask which tests are planned, how to prepare, and whether timing depends on the formulation. Find out who orders the tests, who reviews them, and how you receive an explanation. A result appearing in an online portal is not the same as knowing what it means for your care.
If the service uses a general schedule, ask how it changes for individual circumstances. Do not adopt another patient’s testing calendar or adjust medication based on an isolated value. Your clinician should connect the result to the prescription, symptoms, possible harms, and reason treatment was started.
Sources: Endocrine Society: testosterone therapy clinical guidance
Keep blood pressure in the discussion
The FDA’s 2025 class-wide testosterone update followed evidence including TRAVERSE and ambulatory blood-pressure studies. It removed boxed-warning language about increased adverse cardiovascular outcomes while requiring blood-pressure warnings. The update does not mean that every cardiovascular concern has disappeared or that monitoring is optional.
Ask whether and how you should record blood pressure and who reviews the information. Tell the clinician about existing cardiovascular conditions and relevant medicines. The agency also retained the limitation concerning age-related low testosterone, so the update should not be used as a general endorsement of testosterone for aging.
Sources: FDA: 2025 testosterone labeling and blood pressure changes
Discuss blood counts and other individual risks
Clinical guidance includes monitoring hematocrit and considering prostate-related assessment in the relevant setting. Sleep concerns, medical history, symptoms, and adverse effects can also affect decisions. Ask which checks apply to you and why, rather than treating every laboratory item in an advertised panel as equally necessary.
Fertility goals remain relevant over time. If those goals change, bring the issue to the clinician because exogenous testosterone can suppress sperm production. Our medication and pharmacy guide also explains why a change in formulation or dispenser deserves a fresh review of product-specific information.
Sources: Endocrine Society: testosterone therapy clinical guidance
Understand what the subscription covers
Hone describes different testing and consultation arrangements by membership, Henry Meds advertises bundled care, and TRT Nation lists laboratory charges in its FAQ. Those are different commercial descriptions, not interchangeable medical schedules. Ask which planned visits and tests are included in your own quote and when additional charges might arise.
Our Hone review, Henry review, and TRT Nation review preserve those distinctions. Use the cost planner for known expenses, while keeping unresolved costs visible. A low monthly headline is less useful if you cannot tell what follow-up it actually buys.
Sources: Hone Health: Basic and Premium memberships and starting assessment · Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ · TRT Nation: laboratory costs, state access, and clinical process
Plan for questions between appointments
Ask how to contact the prescribing team, who responds, and what issues should not wait for a routine portal reply. A telehealth messaging channel is not automatically an emergency service. For severe or urgent symptoms, seek appropriate urgent or emergency care rather than waiting for an ordinary scheduled review.
Also ask how to share records with your usual clinician and what happens if you change providers or stop the service. Keep contact information, the prescription details, and upcoming steps together. A good follow-up arrangement should be understandable enough that you know where to turn when something changes.
Sources: Endocrine Society: testosterone therapy clinical guidance
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Checked September 22, 2026; prices and availability can change.
- Endocrine Society: testosterone therapy clinical guidance
- FDA: 2025 testosterone labeling and blood pressure changes
- Hone Health: Basic and Premium memberships and starting assessment
- Henry Meds: TRT plans, costs, eligibility, and cancellation FAQ
- TRT Nation: laboratory costs, state access, and clinical process
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.